Clinical trials recruiting for Prognostic Stage IV Breast Cancer AJCC v8
9
Recruiting trials
45
US states with sites
3
Countries
0%
Accept healthy volunteers
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Pembrolizumab | 2 |
| Abemaciclib | 1 |
| Anti-HER2/HER3 Dendritic Cell Vaccine | 1 |
| Atezolizumab | 1 |
| Avapritinib | 1 |
| Cabozantinib S-malate | 1 |
| Cediranib | 1 |
| Ceralasertib | 1 |
| Ipilimumab | 1 |
| Minoxidil | 1 |
| Nab-paclitaxel | 1 |
| Olaparib | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| New York | 4 |
| Texas | 4 |
| California | 2 |
| Florida | 2 |
| Georgia | 2 |
| Massachusetts | 2 |
| Ohio | 2 |
| Virginia | 2 |
| Alaska | 1 |
| Arizona | 1 |
| Arkansas | 1 |
| Colorado | 1 |
Top cities
Buffalo, New York 3Houston, Texas 3Atlanta, Georgia 2Columbus, Ohio 2Irvine, California 2Aberdeen, Washington 1Adrian, Michigan 1Albuquerque, New Mexico 1Allentown, Pennsylvania 1Alton, Illinois 1
Self-screener
Recruiting trials
- Abemaciclib and Endocrine Therapy in Older Patients With Breast Cancer.
- Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors
- Biomarkers and Clinical Features of Metastatic Breast Cancer in Patients Treated With CDK4/6 Inhibitors
- Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- Olaparib With Cediranib or AZD6738 for the Treatment of Advanced or Metastatic Germline BRCA Mutated Breast Cancer
- Personalized Vaccine Immunotherapy in Combination With Checkpoint Inhibitor for Treatment of Triple Negative Breast Cancer
- Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax
- S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
- Topical or Oral Minoxidil for the Treatment of Endocrine Therapy-Induced Alopecia in Patients With Stage I-IV Breast Cancer
Related conditions
Trials recruiting for Prognostic Stage IV Breast Cancer AJCC v8 often also study these conditions. Each links to its own recruiting-trial list.
Anatomic Stage IV Breast Cancer AJCC v8 43Breast cancer 2239Prognostic Stage IIIC Breast Cancer AJCC v8 6Prognostic Stage IIIB Breast Cancer AJCC v8 5Prognostic Stage IIIA Breast Cancer AJCC v8 5Prognostic Stage III Breast Cancer AJCC v8 5Metastatic Breast Carcinoma 23Anatomic Stage IIIC Breast Cancer AJCC v8 7Anatomic Stage IIIB Breast Cancer AJCC v8 7Anatomic Stage IIIA Breast Cancer AJCC v8 10
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Prognostic Stage IV Breast Cancer AJCC v8 trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.